- Home
- MTEX vs BOLT Comparison
MTEX vs BOLT Comparison
Compare MTEX & BOLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTEX
- BOLT
- Stock Information
- Founded
- MTEX 1993
- BOLT 2015
- Country
- MTEX United States
- BOLT United States
- Employees
- MTEX N/A
- BOLT N/A
- Industry
- MTEX Medicinal Chemicals and Botanical Products
- BOLT Biotechnology: Pharmaceutical Preparations
- Sector
- MTEX Health Care
- BOLT Health Care
- Exchange
- MTEX Nasdaq
- BOLT Nasdaq
- Market Cap
- MTEX 21.2M
- BOLT 22.6M
- IPO Year
- MTEX 1999
- BOLT 2021
- Fundamental
- Price
- MTEX $11.24
- BOLT $0.49
- Analyst Decision
- MTEX
- BOLT Hold
- Analyst Count
- MTEX 0
- BOLT 5
- Target Price
- MTEX N/A
- BOLT $1.25
- AVG Volume (30 Days)
- MTEX 6.5K
- BOLT 114.3K
- Earning Date
- MTEX 03-27-2025
- BOLT 03-20-2025
- Dividend Yield
- MTEX N/A
- BOLT N/A
- EPS Growth
- MTEX N/A
- BOLT N/A
- EPS
- MTEX N/A
- BOLT N/A
- Revenue
- MTEX $121,552,000.00
- BOLT $9,779,000.00
- Revenue This Year
- MTEX N/A
- BOLT $9.87
- Revenue Next Year
- MTEX N/A
- BOLT N/A
- P/E Ratio
- MTEX N/A
- BOLT N/A
- Revenue Growth
- MTEX N/A
- BOLT 35.86
- 52 Week Low
- MTEX $6.75
- BOLT $0.46
- 52 Week High
- MTEX $16.49
- BOLT $1.56
- Technical
- Relative Strength Index (RSI)
- MTEX 46.46
- BOLT 45.52
- Support Level
- MTEX $10.50
- BOLT $0.48
- Resistance Level
- MTEX $11.95
- BOLT $0.52
- Average True Range (ATR)
- MTEX 0.66
- BOLT 0.03
- MACD
- MTEX 0.00
- BOLT 0.00
- Stochastic Oscillator
- MTEX 26.91
- BOLT 40.32
About MTEX Mannatech Incorporated
Mannatech Inc is a wellness solution provider. The company develops and sells nutritional supplements, topical and skin care and anti-aging products, and weight-management products that target optimal health and wellness. Mannatech sells products in three regions: the Americas (the United States, Canada, and Mexico); Europe/the Middle East/Africa (EMEA) (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden, and the United Kingdom); and Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan, Hong Kong, and China). Mannatech generates the majority of its revenue from the Americas.
About BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.